News
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.
Sales of the influenza vaccine, Fluarix, declined 92%. Sales of Established vaccines were down 3%. During the quarter, GSK did not record any sales from the COVID-19 booster vaccine, which was co ...
“Fluarix Tetra (GSK) is no longer marketed, and SKYCellflu (Pharmaniaga Marketing, SK Bioscience Korea) has no stock in the country,” he added. “Currently, there is an unexpected surge in ...
After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has delivered the goods in the all ...
(RTTNews) - GSK (GSK, GSK.L) has started shipping doses of trivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2024-25 flu season. This immediately ...
The company said both FLULAVAL and FLUARIX will be available in a 0.5mL, single-dose, pre-filled syringe and are indicated for people six months of age and older. FLUARIX and FLULAVAL are vaccines ...
GSK supports annual flu immunization by getting FLULAVAL and FLUARIX to patients in advance of flu season PHILADELPHIA, July 11, 2024--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced it ...
GSK supports annual flu immunization by getting FLULAVAL and FLUARIX to patients in advance of flu season PHILADELPHIA, July 11, 2024--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced it has ...
Both FLULAVAL and FLUARIX will be available in a 0.5mL, single-dose, pre-filled syringe and are indicated for people six months of age and older. According to the US Centers for Disease Control ...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
For patients age 50 to 64, the trial compared the combination vaccine against GSK PLC’s GSK Fluarix flu vaccine and Spikevax. Back To Top ...
The other cohort of adults 50 to 64 years of age compared mRNA-1083 to co-administered, Fluarix, a standard dose influenza vaccine, and Spikevax. The immune responses from a single dose of mRNA-1083 ...
In this group, participants have either received mRNA-1083 or a combination of Spikevax and a standard flu vaccine (Fluarix ®). Moderna reports that the immune response elicited by mRNA-1083 was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results